<DOC>
	<DOCNO>NCT01770730</DOCNO>
	<brief_summary>The novel urine LAM point-of-care strip test offer potential clinical utility improve TB diagnosis HIV co-infected patient . Urine LAM strip test performance improve increase illness severity advance immunosuppression , thus offer great potential utility hospitalise HIV-infected patient advanced immunosuppression ( CD4 cell count le 200 ) . However , context high rate empiric treatment availability novel TB diagnostics , clinical impact urine LAM strip test unknown . This study investigate impact urine LAM strip test . The study hypothesis urine LAM strip test , combine standard TB diagnostics ( smear microscopy culture ) significantly improve TB treatment-related outcome ( TB-related mortality , morbidity length hospital stay ) HIV-infected hospitalize patient compare standard TB diagnostics alone .</brief_summary>
	<brief_title>A Trial Urine LAM Strip Test TB Diagnosis Amongst Hospitalized HIV-infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>HIVinfected ( 1x rapid HIV test positive ) Considered TB suspect attend doctor ( must comprise least 1 follow : current fever cough , drench night sweat , selfreported LOW ) Illness severity sufficient warrant hospitalization â‰¥18 year old Provision inform consent HIVuninfected Patients receive antiTB medication 60 day prior test Unable provide 30mls urine Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>urine LAM strip test</keyword>
	<keyword>diagnostics</keyword>
	<keyword>tuberculosis</keyword>
</DOC>